NPS Pharma (NPSP) Reports Q3 Loss of $0.16, Misses by 4c
More News related to NPSP
- NPS Pharma (NPSP) Reports Q3 Loss of $0.16, Misses by 4c
- NPS Pharmaceuticals Reports Third Quarter Results and Improved Cash Burn Guidance
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- NPS Pharmaceuticals to Report Third Quarter Financial Results on November 4, 2009
- Data Demonstrate That GATTEX(TM) (Teduglutide) Improves Lean Body Mass, Mineral Composition and Electrolyte Levels in Patients with Parenteral Nutrition Dependent Short Bowel Syndrome
NPS Pharmaceuticals (NASDAQ: NPSP) reports Q3 loss of $0.16, 4 cents worse than the analyst estimate of ($0.12).
Related Categories
EarningsStocks Mentioned
-0.05Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
